Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Exchange Rate Effect (2019 - 2025)

Historic Exchange Rate Effect for Tandem Diabetes Care (TNDM) over the last 7 years, with Q3 2025 value amounting to $605000.0.

  • Tandem Diabetes Care's Exchange Rate Effect rose 15919.77% to $605000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 63361.7%. This contributed to the annual value of $1.3 million for FY2024, which is 69245.28% up from last year.
  • According to the latest figures from Q3 2025, Tandem Diabetes Care's Exchange Rate Effect is $605000.0, which was up 15919.77% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Exchange Rate Effect ranged from a high of $2.2 million in Q4 2024 and a low of -$1.9 million during Q1 2025
  • For the 5-year period, Tandem Diabetes Care's Exchange Rate Effect averaged around $124526.3, with its median value being $14000.0 (2021).
  • In the last 5 years, Tandem Diabetes Care's Exchange Rate Effect plummeted by 320000.0% in 2022 and then skyrocketed by 1460000.0% in 2023.
  • Over the past 5 years, Tandem Diabetes Care's Exchange Rate Effect (Quarter) stood at $103000.0 in 2021, then surged by 903.88% to $1.0 million in 2022, then crashed by 57.45% to $440000.0 in 2023, then skyrocketed by 392.27% to $2.2 million in 2024, then tumbled by 72.07% to $605000.0 in 2025.
  • Its Exchange Rate Effect stands at $605000.0 for Q3 2025, versus $1.6 million for Q2 2025 and -$1.9 million for Q1 2025.